Giving Severe Hypoglycaemia the Attention it is Due

2018-07-29T18:59:32+00:00ADVANCE trial, Cardiovascular events, DEVOTE study, glucose levels, Hypoglycemia Assessment Tool (HAT) study, ORIGIN trial, Patient education, Severe hypoglycaemia, Type 2 diabetes|

There is a line in the sand between mild and severe hypoglycaemia (SH). While mild hypoglycaemia is not trivial, it does not threaten life and health as SH does. For people who depend on insulin and other glucose-lowering drugs associated with hypoglycaemia, clinicians often consider a degree of SH “the cost of doing business” in diabetes management—in other words, an unwanted but unavoidable corollary of treatment.